Aptorum Group Limited
NASDAQ: APM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ian Huen
- Employees
- 1
- Headquarters
- London, United Kingdom
- IPO year
- 2018
- Market cap
- $5.2M
- Website
- https://www.aptorumgroup.com
Loading APM…
Loading profile data…Frequently asked questions about APM
What does Aptorum Group Limited (APM) do?
Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in phase 1 clinical trial to treat neuroblastoma a...
Where does APM trade?
Aptorum Group Limited (APM) trades on the NASDAQ.
What sector is APM in?
Aptorum Group Limited (APM) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Aptorum Group Limited?
Ian Huen is the chief executive officer of Aptorum Group Limited (APM).
Where is Aptorum Group Limited headquartered?
Aptorum Group Limited is headquartered in United Kingdom.
Does APM pay a dividend?
Aptorum Group Limited (APM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did APM go public?
Aptorum Group Limited (APM) completed its initial public offering in 2018.